What are the traditional uses of Terminalia chebula. How does Terminalia chebula contribute to modern medicine. What chemical compounds are found in Terminalia chebula. How effective is Terminalia chebula as an antioxidant. What clinical studies have been conducted on Terminalia chebula.

The Importance of Terminalia Chebula in Traditional and Modern Medicine

Terminalia chebula, commonly known as Haritaki or Chebulic Myrobalan, is a tree species that has been used in traditional medicine for centuries. It belongs to the Combretaceae family and is native to South Asia. The fruit of this tree has garnered significant attention in the field of medicinal research due to its potential health benefits.

Traditional medicine systems, particularly Ayurveda, have long recognized the therapeutic properties of Terminalia chebula. As global interest in natural remedies grows, researchers are increasingly turning their attention to this plant to explore its potential in modern medicine.

Traditional Uses of Terminalia Chebula

In traditional medicine, Terminalia chebula has been used to treat a wide range of ailments. Some of its common applications include:

• Digestive disorders
• Respiratory issues
• Skin conditions
• Cardiovascular problems
• Diabetes management
• Wound healing

These traditional uses have inspired modern researchers to investigate the scientific basis behind the plant’s therapeutic properties.

Chemical Composition of Terminalia Chebula

The medicinal properties of Terminalia chebula are attributed to its rich chemical composition. Several studies have been conducted to identify and quantify the bioactive compounds present in different parts of the plant, particularly the fruit.

Major Chemical Constituents

Some of the key compounds found in Terminalia chebula include:

• Tannins (chebulagic acid, chebulinic acid, gallic acid)
• Flavonoids (rutin, quercetin)
• Phenolic compounds
• Triterpenoids
• Fatty acids

The concentration of these compounds can vary based on factors such as geographical location, maturity stage of the fruit, and extraction methods used.

Variation in Chemical Composition

Studies have shown that the chemical composition of Terminalia chebula can vary significantly depending on various factors. For instance, Jayaramkumar (2006) found that the content of tannic acid, gallic acid, chebulinic acid, and ethyl gallate in Terminalia chebula fruits varied based on geographical location.

Similarly, Mammen et al. (2012) investigated the variation in constituents of Terminalia chebula fruits at different maturity stages. This research highlights the importance of considering these factors when studying or using the plant for medicinal purposes.

Extraction Methods and Their Impact on Bioactive Compounds

The method of extraction plays a crucial role in determining the type and quantity of bioactive compounds obtained from Terminalia chebula. Researchers have explored various extraction techniques to optimize the yield of desired compounds.

Conventional Extraction Methods

Traditional extraction methods often involve the use of water or organic solvents. For example, Tubtimdee and Shotipruk (2011) studied the extraction of phenolics from Terminalia chebula using water-ethanol and water-propylene glycol mixtures.

Advanced Extraction Techniques

More advanced techniques have also been employed to improve extraction efficiency:

• Supercritical fluid extraction: Zhang et al. (1997) used supercritical CO2 to extract fatty oils from Terminalia chebula.
• Subcritical water extraction: Rangsriwong et al. (2009) explored this method for extracting polyphenolic compounds from Terminalia chebula fruits.
• High-speed counter-current chromatography: Han et al. (2006) used this technique for the preparative isolation of hydrolysable tannins like chebulagic acid and chebulinic acid.

These advanced extraction methods can potentially yield higher concentrations of bioactive compounds, enhancing the therapeutic potential of Terminalia chebula extracts.

Antioxidant Properties of Terminalia Chebula

One of the most studied properties of Terminalia chebula is its potent antioxidant activity. Antioxidants play a crucial role in neutralizing harmful free radicals in the body, which are associated with various diseases and aging processes.

Evaluation of Antioxidant Activity

Several studies have demonstrated the strong antioxidant potential of Terminalia chebula extracts:

• Chang and Lin (2010) developed a pattern recognition method to evaluate the antioxidant activity of Terminalia chebula extracts and its fermented products.
• Naik et al. (2004) conducted studies on the aqueous extract of Terminalia chebula, finding it to be a potent antioxidant and a probable radioprotector.
• Mahesh et al. investigated the effect of Terminalia chebula aqueous extract on oxidative stress and antioxidant status in various experimental models.

These studies collectively suggest that Terminalia chebula could be a valuable source of natural antioxidants with potential applications in healthcare and functional foods.

Mechanisms of Antioxidant Action

The antioxidant activity of Terminalia chebula is primarily attributed to its high content of phenolic compounds, particularly tannins and flavonoids. These compounds can act as free radical scavengers, metal chelators, and enzyme inhibitors, contributing to the plant’s overall antioxidant effect.

Clinical Research on Terminalia Chebula

As interest in Terminalia chebula grows, an increasing number of clinical studies are being conducted to evaluate its therapeutic potential in various health conditions.

Digestive Health

Given its traditional use in treating digestive disorders, several studies have focused on the gastrointestinal effects of Terminalia chebula:

• A clinical trial investigated the efficacy of a herbal formulation containing Terminalia chebula in the treatment of functional constipation.
• Another study examined the potential of Terminalia chebula in managing symptoms of gastroesophageal reflux disease (GERD).

Diabetes Management

The potential of Terminalia chebula in diabetes management has also been explored in clinical settings:

• A randomized, double-blind, placebo-controlled study evaluated the effect of Terminalia chebula extract on postprandial blood glucose levels in type 2 diabetes patients.
• Another clinical trial investigated the long-term effects of Terminalia chebula supplementation on glycemic control and lipid profile in diabetic patients.

Cardiovascular Health

Some clinical studies have focused on the cardiovascular benefits of Terminalia chebula:

• A study examined the effects of Terminalia chebula extract on blood pressure and lipid profile in patients with mild hypertension.
• Another clinical trial investigated the potential of Terminalia chebula in improving endothelial function in patients with coronary artery disease.

Safety and Toxicity Profile of Terminalia Chebula

While Terminalia chebula has been used safely in traditional medicine for centuries, it’s crucial to evaluate its safety profile through modern scientific methods.

Acute and Chronic Toxicity Studies

Several preclinical studies have been conducted to assess the safety of Terminalia chebula:

• Acute toxicity studies in animal models have shown that Terminalia chebula extracts are generally well-tolerated at recommended doses.
• Chronic toxicity studies have evaluated the long-term effects of Terminalia chebula consumption, providing valuable data on its safety for prolonged use.

Human Safety Studies

Clinical trials involving Terminalia chebula have also provided insights into its safety profile in humans:

• Most studies report mild to no adverse effects with the use of Terminalia chebula at recommended doses.
• Some participants have reported mild gastrointestinal discomfort, which is generally transient and resolves without intervention.

Despite these promising safety data, more comprehensive and long-term studies are needed to fully establish the safety profile of Terminalia chebula, especially in specific populations such as pregnant women and individuals with pre-existing medical conditions.

Future Directions in Terminalia Chebula Research

As research on Terminalia chebula continues to evolve, several promising areas for future investigation have emerged:

Advanced Phytochemical Analysis

With advancements in analytical techniques, there’s potential for discovering new bioactive compounds in Terminalia chebula:

• High-resolution mass spectrometry could help identify previously unknown phytochemicals.
• Metabolomics approaches could provide a more comprehensive understanding of the plant’s chemical profile and how it varies under different conditions.

Mechanism of Action Studies

While many therapeutic effects of Terminalia chebula have been observed, the underlying mechanisms are not always fully understood:

• In vitro and in vivo studies focusing on molecular pathways could elucidate how Terminalia chebula exerts its various health benefits.
• Understanding these mechanisms could lead to more targeted and effective use of Terminalia chebula in healthcare.

Drug Development

The diverse bioactive compounds in Terminalia chebula make it a promising source for new drug development:

• Isolation and modification of active compounds could lead to the development of novel pharmaceutical agents.
• Combinatorial approaches, exploring synergistic effects with other natural compounds or conventional drugs, could yield innovative therapeutic strategies.

Clinical Trials

More rigorous clinical trials are needed to establish the efficacy and safety of Terminalia chebula in various health conditions:

• Large-scale, multi-center randomized controlled trials could provide stronger evidence for its therapeutic effects.
• Long-term follow-up studies could assess the sustained benefits and potential side effects of prolonged use.

Standardization and Quality Control

As interest in Terminalia chebula grows, there’s a need for standardized preparation methods and quality control measures:

• Development of standardized extracts with consistent levels of key bioactive compounds could ensure more reliable results in research and clinical use.
• Establishment of quality control parameters and methods could help maintain the integrity and efficacy of Terminalia chebula products in the market.

Potential Applications of Terminalia Chebula in Modern Healthcare

The diverse therapeutic properties of Terminalia chebula suggest numerous potential applications in modern healthcare:

Nutraceuticals and Functional Foods

The strong antioxidant properties of Terminalia chebula make it an excellent candidate for inclusion in nutraceuticals and functional foods:

• Antioxidant-rich supplements could be developed to support overall health and wellness.
• Functional foods fortified with Terminalia chebula extracts could offer added health benefits to consumers.

Topical Formulations

Given its traditional use in skin conditions, Terminalia chebula could be incorporated into various topical formulations:

• Anti-aging creams and lotions could leverage its antioxidant properties to combat skin aging.
• Wound healing ointments could potentially benefit from the tissue regeneration properties of Terminalia chebula.

Adjunct Therapy

Terminalia chebula could potentially be used as an adjunct to conventional therapies in various conditions:

• Its blood glucose-lowering effects could make it a useful complement to diabetes management strategies.
• The cardiovascular benefits of Terminalia chebula could potentially support heart health programs.

Natural Preservatives

The antimicrobial and antioxidant properties of Terminalia chebula extracts could find applications in the food and cosmetic industries:

• Natural preservatives derived from Terminalia chebula could potentially replace synthetic additives in food products.
• Cosmetic formulations could benefit from the preservative effects of Terminalia chebula extracts, potentially extending shelf life while providing additional skin benefits.

As research on Terminalia chebula continues to progress, it’s likely that new and innovative applications will emerge, further cementing its place in modern healthcare and related industries. However, it’s crucial that these potential applications are thoroughly investigated through rigorous scientific studies before being implemented on a large scale.

The development of Terminalia chebula Retz. (Combretaceae) in clinical research

1. World Health Organization . Traditional medicine-growing needs and potential. WHO policy perspectives on medicine, No. 2. WHO/EBM/2002. WHO: Geneva; 2002. [Google Scholar]

2. Koehn FE, Carter GT. The evolving role of natural products in drug discovery. Nat Rev Drug Discov. 2005;4:206–220. [PubMed] [Google Scholar]

3. CSIR . The wealth of India – A dictionary of indian raw materials and industrial products. Vol X. New Delhi: Publication and Information Directorate, CSIR; 2002. pp. 522–524. [Google Scholar]

4. Varier . A dictionary of Indian raw materials and industrial products. New Delhi: Publications and Information Directorate, Council of Scientific and Industrial Research; 2002. p. 387. [Google Scholar]

5. Khare CP. Indian medicinal plants: An illustrated dictionary. Berlin: Springer-Verlag; 2007. pp. 652–653. [Google Scholar]

6. Govt. of India . The Ayurvedic pharmacopoeia of India. New Delhi: Government of India Ministry of Health and Family Welfare Department of Indian System of Medicine & Homoeopathy; 2001. p. 47. [Google Scholar]

7. Gupta AK, Tandon N, Sharma M. Quality standards of Indian medicinal plant. New Delhi: Indian Council of Medical Research; 2003. pp. 207–209. [Google Scholar]

8. Sukhdev SH, Deepak M, Joseph GVR, Joseph S, Nagar G. Indian herbal pharmacopoeia. Vol II. Jammu Tawi: IDM, Mumbai and RRL, CSIR; 1999. pp. 154–159. [Google Scholar]

9. Aslokar LV, Kakkar KK, Chakre OJ. New Delhi: Publications and Information’s Directorate, CSIR; 1992. Glossary of Indian medicinal plants with active principles. [Google Scholar]

10. Kumar A, Lakshman K, Jayaveera K, Satish K, Tripathi SM. Estimation of rutin and quercetin Terminalia chebula by HPLC. Int J Aesth Antiag Med. 2009;2(1):3. [Google Scholar]

11. Jayaramkumar K. Effect of geographical variation on content of tannic acid, gallic acid, chebulinic acid, and ethyl gallate in Terminalia chebula fruits. Nat Prod. 2006;2(3–4):170–175. [Google Scholar]

12. Juang LJ, Sheu SJ, Lin TC. Determination of hydrolyzable tannins in the fruit of Terminalia chebula by high-performancc liquid chromatography and capillary electrophoresis. J Sep Sci. 2004;27(9):718–724. [PubMed] [Google Scholar]

13. Williumson EN. Major herbs of Ayurveda. London: Churchill Livingstone; 2002. p. 299. [Google Scholar]

14. Tubtimdee C, Shotipruk A. Extraction of phenolics from Terminalia chebula Retz. with water-ethanol and water-propylene glycol and sugaring-out concentration of extracts. Sep Puri Tech. 2011;77(3):339–346. [Google Scholar]

15. Thakur M, Rana RC, Thakur S. Physiochemical evaluation of Terminalia chebula fruits. J Non Timber Forest Prod. 2008;15:37–42. [Google Scholar]

16. Rangsriwong P, Rangkadilok N, Satayavivad J, Goto M, Shotipruk A. Subcritical water extraction of polyphenolic compounds from Terminalia chebula Retz. fruits. Sep Puri Tech. 2009;66:51–56. [Google Scholar]

17. Muhammad S, Khan BA, Akhtar N, Mahmood T, Rasul A, Hussain I, et al.et al. The morphology, extractions, chemical constituents and uses of Terminalia chebula: A review. J Med Plants Res. 2012;6(33):4772–4775. [Google Scholar]

18. Yoganarasimhan SN. Medicinal plants of India. Bangalore: Self Publication; 2000. p. 541. [Google Scholar]

19. Zhang X, Chen C, He S, Ge F. Supercritical-CO₂ fluid extraction of the fatty oil in Terminalia chebula and GC-MS analysis. Zhong Yao Cai. 1997;20(9):463–464. [PubMed] [Google Scholar]

20. Mammen D, Bapat S, Sane R. An investigation to variation in constituents in the fruits of Terminalia chebula Retz. at different maturity stages. Int J Pharm Bio Sci. 2012;3(1):416–419. [Google Scholar]

21. Han Q, Song J, Qiao C, Wong L, Xu H. Preparative isolation of hydrolysable tannins chebulagic acid and chebulinic acid from Terminalia chebula by high-speed counter-current chromatography. J Sep Sci. 2006;29(11):1653–1657. [PubMed] [Google Scholar]

22. Bruneton J. Pharmacognosy, phytochemistry, medicinal plants. Paris: Laviosier Publishing; 1995. p. p.333. [Google Scholar]

23. Khare CP. Indian herbal remedies: Rational western therapy, Ayurvedic and other traditional usage, Botany. Berlin: Springer; 2004. pp. 451–452. [Google Scholar]

24. Chang CL, Lin CS. Development of antioxidant activity and pattern recognition of Terminalia chebula Retzius extracts and its fermented products. HungKuang J. 2010;61:115–129. [Google Scholar]

25. Naik GH, Priyadarsini KI, Naik DB, Gangabhagirathi R, Mohan H. Studies on the aqueous extract of Terminalia chebula as a potent antioxidant and a probable radioprotector. Phytomedicine. 2004;11(6):530–538. [PubMed] [Google Scholar]

26. Mahesh R, Bhuvana S, Begum VM. Effect of Terminalia chebula aqueous extract on oxidative stress and antioxidant status in the liver and kidney of young and aged rats. Cell Biochem Funct. 2009;27(6):358–363. [PubMed] [Google Scholar]

27. Hazra B, Sarkar R, Biswas S, Mandal N. Comparative study of the antioxidant and reactive oxygen species scavenging properties in the extracts of the fruits of Terminalia chebula, Terminalia belerica and Emblica officinalis. BMC Comp Alter Med. 2010;10:20. [PMC free article] [PubMed] [Google Scholar]

28. Lee HS, Won NH, Kim KH, Lee H, Jun W, Lee KW. Antioxidant effects of aqueous extract of Terminalia chebula in vitvo and in vitro. Biol Pharm Bull. 2005;28(9):1639–1644. [PubMed] [Google Scholar]

29. Lee HS, Jung SH, Yun BS, Lee KW. Isolation of chebulic acid from Terminalia chebula Retz. and its antioxidant effect in isolated rat hepatocytes. Arch Toxicol. 2007;81(3):211–218. [PubMed] [Google Scholar]

30. Chen X, Sun F, Ma L, Wang J, Qin H, Du G. In vitro evaluation on the antioxidant capacity of triethylchebulate, an aglycone from Terminalia chebula Retz fruit. Indian J Pharmacol. 2011;43(3):320–323. [PMC free article] [PubMed] [Google Scholar]

31. Saleem M, Hushum P, Harkonen K, Pihlaja Inhibition of cancer cell growth by crude extract and phenolics of Terminalia chebula fruit. J Ethnopharmacol. 2002;81:327–336. [PubMed] [Google Scholar]

32. Reddy DB, Reddy TC, Jyotsna G, Sharan S, Priya N, Lakshmipathi V, et al.et al. Chebulagic acid, a COX-LOX dual inhibitor isolated from the fruits of Terminalia chebula Retz., induces apoptosis in COLO-205 cell line. J Ethnopharmacol. 2009;124(3):506–512. [PubMed] [Google Scholar]

33. Grover IS, Bala S. Antimutagenic activity of Terminalia chebula (myroblan) in Salmonella typhimurium. Indian J Exp Biol. 1992;30(4):339–341. [PubMed] [Google Scholar]

34. Gandhi NM, Nayar CKK. Radiation protection by Terminalia chebula some mechanistic aspects. Mol Cell Biochem. 2005;277(1–2):43–48. [PubMed] [Google Scholar]

35. Prasad L, Husain Khan T, Jahengir T, Sultana S. Chemomodulatory effect of Terminalia chebula against nickel chloride-induced oxidative stress and tumor promotion response in male Wistar rats. J Trace Elem Med Biol. 2006;20(4):233–239. [PubMed] [Google Scholar]

36. Lee HS, Jung SH, Yun BS, Lee KW. Isolation of chebulic acid from Terminalia chebula Retz. and its antioxidant effect in isolated rat hepatocytes. Arch Toxicol. 2007;31(3):211–218. [PubMed] [Google Scholar]

37. Tasduq SS, Singh AK, Salti NK, Gupta DK, Suri K. Terminalia chebula fruits prevent liver toxicity caused by sub-chronic adminstration of refampicin, isoniazid and pyrazinamide (PZA) in combination. Hum Exp Toxicol. 2006;25(3):11–18. [Google Scholar]

38. Tasaduq SA, Singh K, Sethi S, Sharma SC, Bedi KL, Singh J, et al.et al. Hepatocurative and antioxidant profile of HP-1, a polyherbal phytomedicine. Hum Exp Toxicol. 2003;22(12):639–645. [PubMed] [Google Scholar]

39. Suchalatha S, Shyamadevi CS. Protective effect of Terminalia chebula against experimental myocardial injury induced by isoproterenol. Indian J Exp Biol. 2004;42(2):174–178. [PubMed] [Google Scholar]

40. Reddy VRC. Cardioprotective activity of the fruit of Terminalia chebula. Fitoterapia. 1990;61:517–525. [Google Scholar]

41. Chang CL, Lin CS, Lai GH, Chen YH, Tuan WC, Hsu CM. Influence of Terminalia chebula extracts on the effect of PC12 cell growth. J Trad Med. 2010;21(1):23–30. [Google Scholar]

42. Minkyun NA, Wan BAE, Kang SS, Min BS, Yoo JK, Yuk OK, et al.et al. Cytoprotective effect on oxidative stress and inhibitory effect on cellular aging of Terminialia chebula fruit. Phytother Res. 2004;18:737–741. [PubMed] [Google Scholar]

43. Lee HS, Koo YC, Suh HJ, Kim KY, Lee KW. Preventive effects of chebulic acid isolated from Terminalia chebula on advanced glycation endproduct-induced endothelial cell dysfunction. J Ethnopharmacol. 2010;131(3):567–574. [PubMed] [Google Scholar]

44. Na M, Bae M, Keng SS, Min BS, Yoo JK, Kamiryo Y, et al.et al. Cytoprotective effect on oxidative stress and inhibitory effect on cellular aging of Terminalia chebula fruit. Phytother Res. 2004;18(9):737–741. [PubMed] [Google Scholar]

45. Kannan VR, Rajasekar GS, Rajesh P, Balasubramanian V, Ramesh N, Solomon EK, et al.et al. Anti-diabetic activity on ethanolic extracts of fruits of Terminalia chebula Retz. Alloxan induced diabetic rats. Am J Drug Discov Dev. 2012;2:135–142. [Google Scholar]

46. Senthilkumar GP, Subramanian SP. Biochemical studies on the effect of Terminalia chebula on the levels of glycoproteins in streptozotocin-induced experimental diabetes in rats. J Appl Biomed. 2008;6:105–115. [Google Scholar]

47. Khan KH, Jain SK. Regular intake of Terminalia chebula can reduce the risk of getting typhoid fever. Adv Biotech. 2009;8(9):10–15. [Google Scholar]

48. Khan KH. The effect of regular intake of Terminalia chebula on oxidative stress in mice originated from Salmonella typhimurium. EurAsia J BioSci. 2009;3:113–121. [Google Scholar]

49. Malckzadeh F, Ehsanifar H, Shahamat N, Levin M, Colwell RR. Antibacterial activity of black myrobalan (Terminalia chebula Retz.) against Helicobactor pyroli. Int J Antimicrob Agent. 2001;18(1):85–88. [PubMed] [Google Scholar]

50. Kim HG, Cho JH, Jeong EY, Lim JH, Lee SH, Lee HS. Growth inhibitory activity of active component from Terminalia chebula fruits against intestinal bacteria. J Food Prot. 2006;69(9):2205–2209. [PubMed] [Google Scholar]

51. Sato Y, Oketani H, Singyouchi K, Ohtsubo T, Kihara M, Shibata H, et al.et al. Extraction and purification of effective antimicrobial constituents of Terminalia chebula Retz. against methicillin- resistant Staphylococcus aureus. Bull Pharm Bull. 1997;20(4):401–404. [PubMed] [Google Scholar]

52. Bonjar GH. Antibacterial screening of plants used in Iranian folkloric medicine. Fitoterapia. 2004;75(2):231–235. [PubMed] [Google Scholar]

53. Aneja KR, Joshi R. Evaluation of antimicrobial properties of fruit extracts of Terminalia chebula against dental caries pathogens. Jundishapur J Microbiol. 2009;2(3):105–111. [Google Scholar]

54. Kannan P, Ramadevi SR, Hopper W. Antibacterial activity of Terminalia chebula fruit extract. Afr J Microbiol Res. 2009;3(4):180–184. [Google Scholar]

55. Rani P, Khullar N. Antimicrobial evaluation of some medicinal plants for their antienteric potential against multi-drug resistant Salmonella typhi. Phytother Res. 2004;18(8):670–673. [PubMed] [Google Scholar]

56. Agrawal A, Gupta A, Choudhary NK, Wadhwa S, Dav K, Goyal S, et al.et al. Antibacterial activity of hydroalcoholic extract of Terminalia chebula Retz. on different Gram-positive and Gram-negative Bacteria. Int J Pharm Biol Arch. 2010;1(4):485–488. [Google Scholar]

57. Bag A, Bhattacharyya SK, Bharati P, Pal NK, Chattopadhyay RR. Antibacterial activity of Chebulic myrobalan (fruit of Terminalia chebula Retz.) extracts against methicillin resistant Staphylococcus aureus and trimethoprim-sulphamethoxazole resistant uropathogenic Escherichia coli. Afr J Plant Sci. 2009;3(2):25–29. [Google Scholar]

58. Bag A, Bhattacharyya SK, Pal NK, Chattopadhyay RR. Synergistic effect of Terminalia chebula against multidrug-resistant uropathogenic Escherichia coli. Med Aromatic Plant Sci Biotech. 2011;5(1):70–73. [Google Scholar]

59. Barazani VO, Sathiyomoorthy P, Shalev R, Vardy D, Golan GA. Screening of South-Indian medicinal plants for anti-fungal activity. Phyther Res. 2003;17(9):1123–1125. [PubMed] [Google Scholar]

60. Dutta BK, Rahman I, Das TK. Antifungal activity of Indian plant extracts. Mycoses. 1998;41(11–12):535–536. [PubMed] [Google Scholar]

61. Mehmood Z, Ahmad I, Mohammad F, Ahmad S. Indian medicinal plants: A potential source of anticandidal Drugs. Pharm Biol. 1999;37(3):237–242. [Google Scholar]

62. Bonjar GH. Inhibition of Clotrimazole-resistant Candida albicans by plants used in Iranian folkloric medicine. Fitoterapia. 2004;75(1):74–76. [PubMed] [Google Scholar]

63. Jeong AHN, Kim CY, Lee JS, Kim TG, Kim SH, Lee CK, et al.et al. Inhibition of HIV-1 integrase by galloyl glucoses from Terminalia chebula and flovonol glycoside gallates from Euphorbia pekinensis. Plant Med. 2002;68:457–459. [PubMed] [Google Scholar]

64. Lee D, Boo K, Woo J, Duan F, Lee K, Kwon T, et al.et al. Anti- bacterial and Anti-viral activities of extracts from Terminalia chebula barks. J Korean Soc Appl Biol Chem. 2011;54(2):295–298. [Google Scholar]

65. Badmaev V, Nowakowski M. Protection of epithelial cells against influenza A virus by plant derived biological response modifier Ledretan-96. Phytother Res. 2000;44(4):245–249. [PubMed] [Google Scholar]

66. Gambari R, Lampronti L. Inhibition of immunodeficiency type-1 virus (HIV-1) life cycle by medicinal plant extracts and plant derived compounds. Adv Phytomed. 2006;2:299–311. [Google Scholar]

67. Kurowa M, Nagasaka K, Hirabayashi T, Uyama S, Sato H, Kagiyama T, et al.et al. Efficacy of traditional herbal medicines in combination with acyclovir against Herpes Simplex Virus-1 infection in vitro and in vitvo. Antiviral Res. 1995;27(1–2):19–37. [PubMed] [Google Scholar]

68. Yukawa TA, Kurokawa M, Sato S, Yoshida Y, Kageyamer S, Hasegawa T, et al.et al. Prophylactic treatment of cytomagalovirus infection with traditional herbs. Antiviral Res. 1996;32(2):63–70. [PubMed] [Google Scholar]

69. Vermani K, Garg S. Herbal medicines for sexually transmitted diseases and AIDS. J Ethnopharmacol. 2002;80:49–66. [PubMed] [Google Scholar]

70. Ma H, Zhao YD, Li K, Kang T. A new alternative to treat swine influenza A virus infection: Extracts from Terminalia chebula Retz. Afr J Microbiol Res. 2010;4(6):497–499. [Google Scholar]

71. Dwivedi S, Dwivedi A, Kapadia R, Kaul S. Anthelmintic activity of alcoholic and aqueous extract of fruits of Terminalia chebula Retz. Ethnobot Leaflets. 2008;12:741–743. [Google Scholar]

72. Sohni YR, Kaimal P, Bhatt RM. The antiamoebic effect of crude drug formulation of herbal extracts against Entamoeba histolytica in vitro and in vitvo. J Ethnopharmacol. 1995;45(1):43–52. [PubMed] [Google Scholar]

73. Bagavan A, Rahuman Al, Kamaraj C, Kaushik NK, Mohanakrishnan D, Sahal D. Antiplasmodial activity of botanical extracts against Plasmodium falciparum. Parasitol Res. 2011;108(5):1099–1109. [PubMed] [Google Scholar]

74. Moeslinger T, Friedl R, Volf I, Brunner M, Koller E, Spieckermann PG. Inhibition of inducible nitric oxide synthesis by the herbal preparation Padma 28 in macrophage cell line. Can J Physiol Pharmacol. 2000;78(11):861–866. [PubMed] [Google Scholar]

75. Nair V, Singh S, Gupta YK. Anti-arthritic and disease modifying activity of Terminalia chebula Retz. in experimental models. J Pharm Pharmacol. 2010;62(12):1801–1806. [PubMed] [Google Scholar]

76. Pratibha N, Saxena VS, Amit A, D’Souza P, Bagchi M, Bagchi D. Anti-inflammatory activities of Aller-7, a novel polyherbal formulation for allergic rhinitis. Int J Tissue React. 2004;26(1–2):43–51. [PubMed] [Google Scholar]

77. Rege NN, Thatte UM, Dahanukar SA. Adaptogenic properties of six Rasayana herbs used in Ayurvedic medicines. Phytother Res. 1999;13:275–291. [PubMed] [Google Scholar]

78. Shin TY, Jeong HG, kim DK, Kim SH, Lee JK, Chae BS, et al.et al. Inhibitory action of water soluble fraction of Terminalia chebula on systematic and local anaphylaxis. J Ethnopharmacol. 2001;74:133–140. [PubMed] [Google Scholar]

79. Maruthappan V, Shree KS. Hypolipidemic activity of Haritaki (Terminalia chebula) in atherogenic diet induced hyperlipidemic rats. J Adv Pharm Tech Res. 2010;1:229–235. [PMC free article] [PubMed] [Google Scholar]

80. Israni DA, Patel KV, Gandhi TR. Anti-hyperlipidemic activity of aqueous extract of Terminalia chebula and Gaumutra in high cholesterol diet fed rats. Int J Pharm Sci. 2010;1(1):48–59. [Google Scholar]

81. Tamhane MD, Thorate SP, Rege NN, Dahanukar SA. Effect of oral administration of Terminalia chebula on gastric emptying: An experimental study. J Postgrad Med. 1997;43(1):12–13. [PubMed] [Google Scholar]

82. Sharma P, Prakash T, Kotresha D, Ansari MA, Sahrm UR, Kumar B, et al.et al. Antiulcerogenic activity of Terminalia chebula fruit in experimentally induced ulcer in rats. Pharm Biol. 2011;49(3):262–268. [PubMed] [Google Scholar]

83. Seyyed AM, Ali V, Mohammad KGN, Peyman M. Spasmogenic activity of the seed of Terminalia chebula Retz in rat small intestine: In vitvo and in vitro studies. Malays J Med Sci. 2011;18(3):18–26. [PMC free article] [PubMed] [Google Scholar]

84. Carounanidy U, Satyanarayanan R, Velmurugan A. Use of an aqueous extract of Terminalia chebula as an anticaries agent: a clinical study. Indian J Dent Res. 2007;18(4):152–156. [PubMed] [Google Scholar]

85. Li K, Diao Y, Zhang H, Wang S, Zhang Z, Yu B, et al.et al. Tannin extracts from immature fruits of Terminalia chebula Fructus Retz. promote cutaneous wound healing in rats. BMC Comp Alter Med. 2011;11:1–9. [PMC free article] [PubMed] [Google Scholar]

86. Vani T, Rajani M, Sarkar S, Shishoo CJ. Antioxidant properties of ayurvedic formulation triphala and its constituents. Int J Pharmacog. 1997;35:313–317. [Google Scholar]

87. Aher VD. Immunomodulatory effect of alcoholic extract of Terminalia chebula ripe fruits. J Pharm Sci Res. 2010;2(9):539–544. [Google Scholar]

88. Mukherjee P, Roy S, Bhattacharyya S, Debnath PK, Jan U, Pandit S, et al.et al. Clinical study of Triphala- a well known phytomedicine from India. Indian J Pharmcol Ther. 2006;5:51–54. [Google Scholar]

89. Singh RH, Sinha BN. Clinical and physiological studies on the effect of an indigenous compound Rasayana drug in apparently normal aged person. J Res Indian Med Yoga Homoeo. 1978;13:1–8. [Google Scholar]

90. Amit VS, Saxena N, Prativa M, Bagchi D, Bagchi J. Safety of novel botanical extract formula for ameliorating allergic rhinitis. Toxicol Mechanisms Methods. 2004;13(4):253–261. [PubMed] [Google Scholar]

91. Panunto W, Jaijoy K, Lerdvuthisopon N, Lertprasertsuke N, Jiruntanat N, Soonthornchareonnon N, et al.et al. Acute and chronic toxicity studies of the water extract from dried fruits of Terminalia chebula Rezt. in rats. Int J Appl Res Nat Prod. 2011;3(4):36–43. [Google Scholar]

92. Ji-hoon K, Yun-chang K, Chung-Oui H, Sung-Yong Y, Woojin J, Lee K. Mutagenicity and oral toxicity studies of Terminalia chebula. Phytother Res. 2012;26:39–47. [PubMed] [Google Scholar]

93. Ponnusankar S, Pandit S, Venkatesh M, Bandyopadhyay A, Mukherjee PK. Cytochrome P450 inhibition assay for standardized extract of Terminaliachebula Retz. Phytother Res. 2011;25(1):151–154. [PubMed] [Google Scholar]

94. Arora S, Brits E, Kaur S, Kaur K, Sohi RS, Kumar S, et al.et al. Evaluation of genotoxicity of medicinal plant extracts by the Comet and VITOTOX tests. J Environ Pathol Toxicol Oncol. 2005;24(3):193–200. [PubMed] [Google Scholar]

95. Rathore HS, Makwama M. Prevention of lead toxicity in Allium cepa root tip cells withmyrobalan (fruit of Terminalia chebula Retz.) Biochem Cell Arch. 2005;5(2):169–176. [Google Scholar]

96. Rathore HS, Shazia B, Sharma A, Makwana M. Prevention of aluminium chloride- induced mitodepression with myrobalan (fruit of Terminalia chebula Retz, Combretaceae) in Allium cepa model. Ethnobot leaflets. 2006;10:272–279. [Google Scholar]

Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews

Overview

Terminalia is a tree. Terminalia arjuna, Terminalia bellirica, and Terminalia chebula are three species used in medicine, especially Ayurvedic medicine.

Terminalia contains ingredients that help stimulate the heart. It might also help the heart by lowering cholesterol and blood pressure. Terminalia arjuna is used for its bark, while Terminalia bellirica and Terminalia chebula are used for their fruits.

People use terminalia for heart disease, heart failure, high cholesterol, diabetes, high blood pressure, and many other conditions, but there is no good scientific evidence to support these uses.

Uses & Effectiveness ?

We currently have no information for TERMINALIA overview.

Side Effects

When taken by mouth: Terminalia arjuna is possibly safe when used for up to 3 months. But don’t use Terminalia arjuna without medical supervision. It might affect your heart.

There isn’t enough reliable information to know if other species of Terminalia, including Terminalia bellirica or Terminalia chebula, are safe or what the side effects might be.

Special Precautions and Warnings

When taken by mouth: Terminalia arjuna is possibly safe when used for up to 3 months. But don’t use Terminalia arjuna without medical supervision. It might affect your heart.

There isn’t enough reliable information to know if other species of Terminalia, including Terminalia bellirica or Terminalia chebula, are safe or what the side effects might be. Pregnancy: Terminalia is possibly unsafe when taken by mouth during pregnancy. Stay on the safe side and avoid using any Terminalia species.

Breast-feeding: There isn’t enough reliable information to know if Terminalia is safe to use when breast-feeding. Stay on the safe side and avoid use.

Bleeding disorders: Terminalia might slow blood clotting. This might increase the risk of bruising and bleeding in people with bleeding disorders.

Surgery: Terminalia might interfere with blood sugar control and increase the risk of bleeding during surgery. Stop taking Terminalia at least 2 weeks before a scheduled surgery.

Interactions ?

Moderate Interaction

Be cautious with this combination

• Terminalia bellirica and Terminalia chebula might lower blood sugar levels. Taking Terminalia bellirica or Terminalia chebula along with diabetes medications might cause blood sugar to drop too low. Monitor your blood sugar closely.

• Terminalia arjuna might slow blood clotting. Taking Terminalia arjuna along with medications that also slow blood clotting might increase the risk of bruising and bleeding.

• Some medications are changed and broken down by the liver. Terminalia arjuna might change how quickly the liver breaks down these medications. This could change the effects and side effects of these medications.

• Some medications are changed and broken down by the liver. Terminalia arjuna might change how quickly the liver breaks down these medications. This could change the effects and side effects of these medications.

• Some medications are changed and broken down by the liver. Terminalia arjuna might change how quickly the liver breaks down these medications. This could change the effects and side effects of these medications.

• The body breaks down omeprazole to get rid of it. Terminalia chebula might decrease how quickly the body breaks down omeprazole. Taking Terminalia chebula along with omeprazole might increase the effects and side effects of omeprazole.

• The body breaks down chlorzoxazone to get rid of it. Terminalia chebula might decrease how quickly the body breaks down chlorzoxazone. Taking Terminalia along with chlorzoxazone might increase the effects and side effects of chlorzoxazone.

Dosing

Terminalia arjuna has most often been used by adults in doses of 500 mg by mouth three times daily for up to 3 months. Terminalia chebula has most often been used by adults in doses of 200 mg by mouth 2-3 times daily for up to 3 months. There isn’t enough reliable information to know what an appropriate dose of Terminalia bellirica might be. Keep in mind that terminalia can affect the heart. Speak with a healthcare provider to find out what species and dose might be best for a specific condition.

View References

You Might Also Like

View More

CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is provided by Natural Medicines Comprehensive Database Consumer Version. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
© Therapeutic Research Faculty 2020.

Terminalia Chebula / Terminalia Belerica in Russian – Product

Terminalia Chebula / Terminalia Belerica in Russian – Product – Medication.net

0008

Medicine.net

• Overview
• Benefits
• Side effects
• Precautions
• Interactions
• Contraindications

Overview

Salt composition ica is indicated for Chronic diarrhea, Nervous weakness, Nervous excitability, Chronic cough, Sore throat , Choking, Urinary incontinence, Urinary retention, Urticaria, Bile duct disorders and other conditions.

Detailed information on Terminalia Chebula / Terminalia Belerica / Terminalia Belerica / Terminalia Chebula / Terminalia Belerica is provided below:

Uses , prevention and improvement of the following diseases, conditions and symptoms:

• Chronic diarrhea
• Nervous weakness
• Nervous excitability
• Chronic cough
• Sore throat
• Choking
• Urination disorder
• Urinary retention
• Urticaria
• Bile duct disorders

Learn more: Benefits

Side effects

For this information please consult your physician, pharmacist or read the information on the product packaging.

Precautions

Before starting this drug, tell your doctor about any medications you are taking, dietary supplements (such as vitamins, natural supplements, etc.), allergies, existing medical conditions, and current health conditions (such as pregnancy, upcoming surgery, and etc.). The side effects of the drug may be more pronounced depending on the state of your body. Take this medicine as directed by your doctor, or follow the directions for use that come with your medicine. The dosage of the drug depends on your condition. Tell your doctor if there is no change or if your condition worsens. Important points to discuss with your healthcare provider are listed below.

• Pregnant, planning to become pregnant or breastfeeding
• Breastfeeding

ia Belerica is subject to change. Tell your healthcare provider about all medications, vitamins, and supplements you use. Your doctor will be able to make the right plan for taking the drug, which will avoid negative interactions. Terminalia Chebula / Terminalia Belerica may interact with the following drugs and products:

• Aspirin
• Warfarin

FAQ

• Is it safe to drive or operate heavy machinery while using this product?

  If you experience drowsiness, dizziness, hypotension or a headache as side-effects when using Terminalia Chebula / Terminalia Belerica medicine then it may not be safe to drive a vehicle or operate heavy machinery. You should stop driving if taking this medicine makes you drowsy, dizzy, or hypotensive. Doctors recommend that you stop drinking alcohol with such drugs, because. alcohol greatly increases the side effects and drowsiness. Please check for reactions to your body when using Terminalia Chebula / Terminalia Belerica / Terminalia Chebula / Terminalia Belerica. Be sure to consult your doctor for advice based on the characteristics of your body and general health.

• Is this drug (product) addictive or addictive?

  Most drugs are not habit-forming or addictive. In most cases, the state classifies drugs that can be addictive as controlled dispensing drugs. For example, schedule H or X in India and schedule II-V in the USA. Please check the information on the drug packaging to make sure that this drug is not in the controlled category. Also, do not self-medicate or accustom your body to medications without consulting your doctor.

• Can I stop using this product immediately or do I need to slowly stop using it?

  Some medications need to be stopped gradually due to a rebound effect. Be sure to consult your healthcare provider for advice based on your body, general health, and other medications you may be taking.

Cite this page

Page URL

HTML Link

Terminalia Chebula / Terminalia Belerica

APA Style Citation

900 06 Terminalia Chebula / Terminalia Belerica / Terminalia Chebula / Terminalia Belerica in Russian – Product – Medicine . net. (n.d.). Retrieved April 05, 2023, from https://www.medicine.net/medicine-ru/terminalia-chebula-terminalia-belerica

MLA Style Citation

• “Terminalia Chebula / Terminalia Belerica / Terminalia Chebula / Terminalia Belerica in Russian – Product – Medicine.net” Tabletwise.com . N.p., n.d. Web. 05 Apr. 2023.

Chicago Style Citation

• “Terminalia Chebula / Terminalia Belerica / Terminalia Chebula / Terminalia Belerica in Russian – Product – Medicine.net” Tabletwise. Accessed April 05, 2023. https://www.Medication.net/medicine-ru/terminalia-chebula-terminalia-belerica.

More information about Terminalia Chebula / Terminalia Belerica / Terminalia Chebula / Terminalia Belerica

• Uses
• Reviews

• ia Belerica?
• What are the side effects of Terminalia Chebula / Terminalia Belerica / Terminalia Chebula / Terminalia Belerica?
• What drugs does Terminalia Chebula / Terminalia Belerica interact with?
• When should you not take Terminalia Chebula / Terminalia Belerica?
• What precautions should you take while using Terminalia Chebula / Terminalia Belerica?

Last update date

This page was updated on 9/28/2020.

This page provides information for Terminalia Chebula / Terminalia Belerica Product in English .

Share with friends, get 20% off

Invite your friends to TabletWise learning marketplace. For each purchase they make, you get 20% off (upto $10) on your next purchase.

Terminalia Chebula in Russian – Product

Terminalia Chebula / Terminalia Chebula in Russian – Product – Medicine

Medicine.net

• Overview
• Benefits
• Side effects
• Precautions

90 006 Interactions

• Contraindications

Overview

Terminalia Chebula Salt is indicated for Chronic diarrhoea, Nervous weakness, nervous irritability, chronic cough, sore throat, choking, urination disorder, urinary retention, urticaria and other conditions.

Detailed information on Terminalia Chebula / Terminalia Chebula’s uses, side effects, interactions, and reviews is provided below:

• Chronic diarrhea
• Nervous weakness
• Nervous excitability
• Chronic cough
• Sore throat
• Choking
• Urination disorder
• Urinary retention
• Urticaria

Learn more: Benefits

ophthalmic effects

For this information, please consult your physician, pharmacist or product packaging.

Precautions

Before taking this drug, tell your doctor about any medications you are taking, dietary supplements (such as vitamins, natural supplements, etc.), allergies, existing medical conditions, and current health conditions (such as pregnancy, upcoming surgery, and etc.). The side effects of the drug may be more pronounced depending on the state of your body. Take this medicine as directed by your doctor, or follow the directions for use that come with your medicine. The dosage of the drug depends on your condition. Tell your doctor if there is no change or if your condition worsens. Important points to discuss with your healthcare provider are listed below.

• Breastfeeding

If you take other drugs or supplements at the same time as this drug, the effects of Terminalia Chebula may change. Tell your healthcare provider about all medications, vitamins, and supplements you use. Your doctor will be able to make the right plan for taking the drug, which will avoid negative interactions. Terminalia Chebula may interact with the following drugs and products:

• Aspirin
• Warfarin

FAQ

• Is it safe to drive or operate heavy machinery while using this product?

  If you experience drowsiness, dizziness, hypotension or a headache as side-effects when using Terminalia Chebula medicine then it may not be safe to drive a vehicle or operate heavy machinery. You should stop driving if taking this medicine makes you drowsy, dizzy, or hypotensive. Doctors recommend that you stop drinking alcohol with such drugs, because. alcohol greatly increases the side effects and drowsiness. Please check for these effects on your body when using Terminalia Chebula. Be sure to consult your doctor for advice based on the characteristics of your body and general health.

• Is this drug (product) addictive or addictive?

  Most drugs are not habit-forming or addictive. In most cases, the state classifies drugs that can be addictive as controlled dispensing drugs. For example, schedule H or X in India and schedule II-V in the USA. Please check the information on the drug packaging to make sure that this drug is not in the controlled category. Also, do not self-medicate or accustom your body to medications without consulting your doctor.

• Can I stop using this product immediately or do I need to slowly stop using it?

  Some medications need to be stopped gradually due to a rebound effect. Be sure to consult your healthcare provider for advice based on your body, general health, and other medications you may be taking.

Cite this page

Page URL

HTML Link

Terminalia Chebula

APA Style Citation

• Terminalia Chebula in Russian – Goods – Medicine.net. (n.d.). Retrieved May 03, 2023, from https://www.Medication.